Global Rare Genetic Disease Diagnosis Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Rare Genetic Disease Diagnosis Solution
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Rare Genetic Disease Diagnosis Solution by Type
  • 1.3.1 Overview: Global Rare Genetic Disease Diagnosis Solution Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Rare Genetic Disease Diagnosis Solution Consumption Value Market Share by Type in 2022
  • 1.3.3 Genetic Testing
  • 1.3.4 Biochemical Testing
  • 1.3.5 Imaging and Diagnostic Procedures
  • 1.3.6 Others
• 1.4 Global Rare Genetic Disease Diagnosis Solution Market by Application
  • 1.4.1 Overview: Global Rare Genetic Disease Diagnosis Solution Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Clinical Genetics and Pediatric Clinic
  • 1.4.3 Newborn Screening Program
  • 1.4.4 Research and Development
  • 1.4.5 Others
• 1.5 Global Rare Genetic Disease Diagnosis Solution Market Size & Forecast
• 1.6 Global Rare Genetic Disease Diagnosis Solution Market Size and Forecast by Region
  • 1.6.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Region, (2018-2029)
  • 1.6.3 North America Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
  • 1.6.6 South America Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Retrophin
  • 2.1.1 Retrophin Details
  • 2.1.2 Retrophin Major Business
  • 2.1.3 Retrophin Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.1.4 Retrophin Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Retrophin Recent Developments and Future Plans
• 2.2 3billion
  • 2.2.1 3billion Details
  • 2.2.2 3billion Major Business
  • 2.2.3 3billion Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.2.4 3billion Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 3billion Recent Developments and Future Plans
• 2.3 23andMe
  • 2.3.1 23andMe Details
  • 2.3.2 23andMe Major Business
  • 2.3.3 23andMe Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.3.4 23andMe Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 23andMe Recent Developments and Future Plans
• 2.4 Ancestry
  • 2.4.1 Ancestry Details
  • 2.4.2 Ancestry Major Business
  • 2.4.3 Ancestry Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.4.4 Ancestry Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Ancestry Recent Developments and Future Plans
• 2.5 GeneDx
  • 2.5.1 GeneDx Details
  • 2.5.2 GeneDx Major Business
  • 2.5.3 GeneDx Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.5.4 GeneDx Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 GeneDx Recent Developments and Future Plans
• 2.6 Ambry Genetics
  • 2.6.1 Ambry Genetics Details
  • 2.6.2 Ambry Genetics Major Business
  • 2.6.3 Ambry Genetics Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.6.4 Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Ambry Genetics Recent Developments and Future Plans
• 2.7 QIAGEN
  • 2.7.1 QIAGEN Details
  • 2.7.2 QIAGEN Major Business
  • 2.7.3 QIAGEN Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.7.4 QIAGEN Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 QIAGEN Recent Developments and Future Plans
• 2.8 Illumina
  • 2.8.1 Illumina Details
  • 2.8.2 Illumina Major Business
  • 2.8.3 Illumina Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.8.4 Illumina Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Illumina Recent Developments and Future Plans
• 2.9 PerkinElmer
  • 2.9.1 PerkinElmer Details
  • 2.9.2 PerkinElmer Major Business
  • 2.9.3 PerkinElmer Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.9.4 PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 PerkinElmer Recent Developments and Future Plans
• 2.10 Strand Life Sciences
  • 2.10.1 Strand Life Sciences Details
  • 2.10.2 Strand Life Sciences Major Business
  • 2.10.3 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product and Solutions
  • 2.10.4 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Strand Life Sciences Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Rare Genetic Disease Diagnosis Solution Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Rare Genetic Disease Diagnosis Solution by Company Revenue
  • 3.2.2 Top 3 Rare Genetic Disease Diagnosis Solution Players Market Share in 2022
  • 3.2.3 Top 6 Rare Genetic Disease Diagnosis Solution Players Market Share in 2022
• 3.3 Rare Genetic Disease Diagnosis Solution Market: Overall Company Footprint Analysis
  • 3.3.1 Rare Genetic Disease Diagnosis Solution Market: Region Footprint
  • 3.3.2 Rare Genetic Disease Diagnosis Solution Market: Company Product Type Footprint
  • 3.3.3 Rare Genetic Disease Diagnosis Solution Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Rare Genetic Disease Diagnosis Solution Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Rare Genetic Disease Diagnosis Solution Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Rare Genetic Disease Diagnosis Solution Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Rare Genetic Disease Diagnosis Solution Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
• 6.2 North America Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
• 6.3 North America Rare Genetic Disease Diagnosis Solution Market Size by Country
  • 6.3.1 North America Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
  • 6.3.2 United States Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
• 7.2 Europe Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
• 7.3 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country
  • 7.3.1 Europe Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 7.3.3 France Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region
  • 8.3.1 Asia-Pacific Rare Genetic Disease Diagnosis Solution Consumption Value by Region (2018-2029)
  • 8.3.2 China Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 8.3.5 India Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
• 9.2 South America Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
• 9.3 South America Rare Genetic Disease Diagnosis Solution Market Size by Country
  • 9.3.1 South America Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Rare Genetic Disease Diagnosis Solution Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Rare Genetic Disease Diagnosis Solution Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country
  • 10.3.1 Middle East & Africa Rare Genetic Disease Diagnosis Solution Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Rare Genetic Disease Diagnosis Solution Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Rare Genetic Disease Diagnosis Solution Market Drivers
• 11.2 Rare Genetic Disease Diagnosis Solution Market Restraints
• 11.3 Rare Genetic Disease Diagnosis Solution Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Rare Genetic Disease Diagnosis Solution Industry Chain
• 12.2 Rare Genetic Disease Diagnosis Solution Upstream Analysis
• 12.3 Rare Genetic Disease Diagnosis Solution Midstream Analysis
• 12.4 Rare Genetic Disease Diagnosis Solution Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source